Denmark cancer cases reached their highest recorded level in 2025, with 49,480 people diagnosed during the year, according to new figures from the Danish Health Data Authority (Sundhedsdatastyrelsen). The increase reflects a larger and older population rather than a higher individual risk: once age and population growth are taken into account, the risk of being diagnosed with cancer has fallen by two percent since 2016.
More diagnoses reflect an older Denmark
The new figures mark the highest annual number of cancer diagnoses ever registered in Denmark. Compared with 2016, the total number of new cases has increased by 13 percent.
The Danish Health Data Authority said the rise should be interpreted in light of demographic change. Denmark now has more residents, and people live longer, increasing the number of years in which cancer can develop.
“The increasing number of new cancer cases is due to the fact that more people live in Denmark, and that we live longer, so we simply have more years in which we can get cancer,” said Mette Keis Jepsen, head of department at the Danish Health Data Authority. “This must be taken into account when comparing diseases over time — and when we do that, the risk of getting cancer has actually fallen by two percent since 2016.”
The figures come from Denmark’s Cancer Registry (Cancerregisteret), which records all newly diagnosed cancer cases in the country and is used for statistics, research and healthcare planning.
Denmark cancer risk is falling, especially among men
The overall trend is not the same for all groups. Men still have a higher risk of developing cancer than women, but the decline in risk has been strongest among men.
Several cancer types have shown clear decreases. According to Danish media citing the new data, cases of colorectal cancer fell between 2016 and 2025, especially among men. Cervical cancer also declined among women over the same period.
At the same time, skin cancer has become more prominent in the statistics. In 2025, skin cancer accounted for 13 percent of all new cancer cases among men and 11 percent among women. Part of the increase is linked to changes in registration practices introduced in 2020, when an additional type of skin change was included in the category.
The data underline the complexity of Denmark’s cancer picture: the absolute number of diagnoses is rising, but age-adjusted risk is moving slightly downward.
Survival rates are improving across the health system
While more people are being diagnosed, cancer survival has also improved. In 2010–2012, 63 percent of newly diagnosed cancer patients were still alive five years after their diagnosis. In 2022–2024, that share had risen to 72 percent.
“There are major differences in prospects depending on which type of cancer a person has. But overall, the chance of survival has improved significantly,” Mette Keis Jepsen said.
Earlier figures from the Danish Health Data Authority showed that five-year survival has improved not only for cancers covered by national screening programmes, but also for several serious cancers outside those programmes. Denmark screens for breast cancer, cervical cancer and colorectal cancer.
A growing challenge for Nordic healthcare
Around 420,000 people in Denmark now live with or after cancer, including approximately 230,000 women and 190,000 men. This reflects a major shift for the healthcare system: cancer is increasingly a disease that many people survive, but also one that can require long-term follow-up, rehabilitation and support for late effects.
Denmark’s cancer burden remains high in a Nordic and European context. The OECD and European Commission’s 2025 country cancer profile found that Denmark’s estimated cancer incidence and mortality remain above the EU average, even as cancer mortality has fallen over the past decade.
The latest figures therefore point in two directions at once. Denmark is recording more cancer diagnoses than ever before, largely because of demographic change. But survival is improving, and the age-adjusted risk of cancer has fallen slightly since 2016. For Danish policymakers, the coming challenge will be to combine prevention, early detection and treatment capacity with long-term care for a growing number of cancer survivors.
